News

FDA Authorizes Bivalent COVID-19 Boosters

September 02, 2022

FDA has issued an emergency use authorization for both the Pfizer-BioNTech and Moderna bivalent COVID-19 boosters.

Bio-Rad Launches Anti-Evolocumab Antibodies

September 02, 2022

Bio-Rad’s new antibodies are designed to develop highly selective pharmacokinetic (PK) and anti-drug antibody (ADA) assays for evolocumab and its biosimilars.

Roche Launches Digital PCR System

September 02, 2022

Roche’s Digital LightCycler System is designed to aid in diagnostics for cancer, genetic disease, and infection.

Vaccine Disconnect

September 02, 2022

More than anything else MonkeyPox and COVID-19 have shown that we are interdependent, no matter what continent you call home.

Winter is Coming!

September 02, 2022

As winter approaches, the next generation of COVID-19 vaccines are being prepared and scheduled, ready for distribution across Europe and the world.

What Does Cost Mean?

September 02, 2022

While the cost of certain medicines are alarmingly high, they can be considered a bargain measured against a lifetime of traditional costs.

Lonza Strengthens Micronization Portfolio with the Introduction of X-Ray Powder Diffraction

August 31, 2022

Lonza has introduced X-ray powder diffraction capability at its Monteggio, Switzerland site.

Forecyte Bio and Cytiva to Collaborate on Cell and Gene Therapy Manufacturing and Development

August 31, 2022

Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.

Emerson Opens Gas Analysis Solutions Center in Scotland

August 30, 2022

Emerson’s new gas analysis solutions center, located in Cumbernauld, Scotland, intends to help plants meet sustainability goals.

Thermo Fisher Scientific Opens Viral Vector Manufacturing Site in Massachusetts

August 30, 2022

Thermo Fisher Scientific’s new 300,000 ft² facility, located in Plainville, Mass., will specialize in manufacturing viral vectors.